Author:
Varatharajan Savitha,Panetta John C.,Abraham Ajay,Karathedath Sreeja,Mohanan Ezhilpavai,Lakshmi Kavitha M.,Arthur Nancy,Srivastava Vivi M.,Nemani Sandeep,George Biju,Srivastava Alok,Mathews Vikram,Balasubramanian Poonkuzhali
Funder
Department of Biotechnology , Ministry of Science and Technology
Indian Council of Medical Research
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference33 articles.
1. Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK et al (2010) Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115(3):453–474
2. Dombret H, Gardin C (2016) An update of current treatments for adult acute myeloid leukemia. Blood 127(1):53–61
3. Kokenberg E, Sonneveld P, Sizoo W, Hagenbeek A, Löwenberg B (1988) Cellular pharmacokinetics of daunorubicin: relationships with the response to treatment in patients with acute myeloid leukemia. J Clin Oncol Off J Am Soc Clin Oncol 6(5):802–812
4. Speth PA, Linssen PC, Boezeman JB, Wessels HM, Haanen C (1987) Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion. Cancer Chemother Pharmacol 20(4):311–315
5. Greene W, Huffman D, Wiernik PH, Schimpff S, Benjamin R, Bachur N (1972) High-dose daunorubicin therapy for acute nonlymphocytic leukemia: correlation of response and toxicity with pharmacokinetics and intracellular daunorubicin reductase activity. Cancer 30(6):1419–1427
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献